Nitin Gadkari, Union Minister of Road Transport & Highways, Micro, Small & Medium Enterprises on Thursday afternoon visited Genetic life Sciences Wardha. Gadkari also thanked everyone who is associated with this project and who took efforts to initiate the production of the life-saving drug in the region. Thirty thousand vials will be manufactured daily.
Genetic Life sciences started the production of Remdisivir by partnering with multinational brand Hetero. Hetero’s Remdisivir that goes by the name ‘Covifor’ is a Patent of Hetero causing a delay in the production of the life-saving drug in the country. Gadkari told the media that “Hetero has the patent of Remdisivir and thus it was very difficult to start production in India. It is a matter of great relief that we have started the first Plant in the country that manufactures Remdisivir in Wardha.†He also thanked all the people associated with this project for there contribution in speeding up the process of authorization and production of Covifor.
The production of Remdisivir in the region is a huge relief for the people in Vidarbha as Gadkari told the media that Remdisivir manufactured in the region will be used for the people of Vidarbha and excess drugs will be supplied to other parts of the state and the country. Earlier in the end of April, Gadkari told the media that Genetek Life science will have the capacity to produce thirty thousand vials of remdisivir per day.
Remdisivir is constantly on headlines from the past few months as there is a mass shortage of the drug in the country. Remdisivir is considered one of the most effective medicine for treating moderate to severe patients of Covid-19. Taking advantage of the helplessness of the patients, many people were also caught selling remdisivir at high rates and even selling fake Remdisivir.
